A Crossover Study of Clocapramine and Haloperidol in Chronic Schizophrenia

@article{Yamagami1985ACS,
  title={A Crossover Study of Clocapramine and Haloperidol in Chronic Schizophrenia},
  author={S. Yamagami},
  journal={Journal of International Medical Research},
  year={1985},
  volume={13},
  pages={301 - 310}
}
  • S. Yamagami
  • Published 1985
  • Medicine
  • Journal of International Medical Research
Therapeutic efficacy and target symptoms with clocapramine were compared with those with haloperidol by the crossover method, in a total of 26 chronic schizophrenic patients, by administration of one of the drugs for the first 14 weeks and the other for the next 14 weeks. The final global improvement rating showed no significant difference between the two groups, but clocapramine administered as first drug appeared to have a more pronounced effect than haloperidol. According to the improvement… Expand
3 Citations
Sulpiride for schizophrenia.
TLDR
Sulpiride may be an effective antipsychotic drug but evidence is limited and data relating to claims for its value against negative symptoms is not trial-based. Expand
Clocapramine-related fatality. Postmortem drug levels in multiple psychoactive drug poisoning.
TLDR
The human case has demonstrated drugs with higher Vd values showed higher degree of postmortem redistribution of the drug and vice versa, and postmortem drug redistribution showed great site-dependent variations with the lowest level in the FV blood. Expand
Augmentation of paroxetine with clocapramine in panic disorder

References

SHOWING 1-10 OF 18 REFERENCES
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA
TLDR
In a double-blind trial in which 45 patients with acute schizophrenia took part the alpha-isomer of flupenthixol was found to be significantly more effective than both beta-flupenthIXol (which does not) and placebo, suggesting that the antipsychotic effect occurs in patients with typically schizophrenic illnesses but may be limited to positive symptoms. Expand
Comparison of Efficacy of Timiperone, a New Butyrophenone Derivative, and Clocapramine in Schizophrenia: A Multiclinic Double-Blind Study
TLDR
From these results, including the analysis by stratification, it was considered that timiperone was a superior or equivalent neuroleptic in comparison with clocapramine against the negative symptoms as well as the positive ones of chronic schizophrenia, and was equally safe or safer than clocabramine. Expand
High-dose propranolol in schizophrenia.
  • G. Sheppard
  • Medicine
  • The British journal of psychiatry : the journal of mental science
  • 1979
TLDR
Eight male schizophrenics were treated in an open study with d.l. propranolol and seven patients showed significant clinical evidence of psychiatric improvement, while the incidence of toxic side-effects was low. Expand
A study on the pharmacological and biochemical profile of clocapramine.
TLDR
Pharmacological and biochemical studies were carried out in order to elucidate the central action of clocapramine and the correlation between the preclinical findings so far obtained and clinical disinhibitory activity is discussed. Expand
PROPRANOLOL AS AN ADJUNCT TO THE TREATMENT OF SCHIZOPHRENIA
Propranolol contributed usefully to the practical management of patients with chronic schizophrenia whose florid symptoms had not remitted with major tranquillisers. 14 patients who had received anExpand
Impact of neuroleptic chemotherapies on schizophrenic psychoses.
  • P. Deniker
  • Psychology, Medicine
  • The American journal of psychiatry
  • 1978
TLDR
The author reviews the impact of neuroleptic chemotherapy on various forms of schizophrenia in the 25 years since the introduction of chlorpromazine in psychiatry, with an emphasis on the "dual structure" of the illness. Expand
Interaction of neuroleptics and antidepressants with rat brain alpha 2-receptors: a possible relationship between alpha 2-receptor antagonism and antidepressant action.
TLDR
The suggestion that some neuroleptics enhance the release of norepinephrine (NE) mainly by acting on presynaptic alpha 2-receptors is supported, and it is concluded that a number of neuroleptic drugs and antidepressant agents display a potent or moderate affinity to alpha 1-receptor sites. Expand
Molecular pathology of schizophrenia: more than one disease process?
  • T. Crow
  • Medicine
  • British medical journal
  • 1980
TLDR
In Florence showed some symptomatic improvement with only minor side effects, but this requires confirmation in a controlled trial, and another approach is based on the finding that suppressor lymphocyte activity is depressed during acute relapses in multiple sclerosis. Expand
A standardized psychiatric assessment scale for rating chronic psychotic patients
Simple 5‐point scales are described together with the method used to study their reliability, the results of which are shown. The scales are short, easy to administer and sensitive to change,Expand
Clinical evaluation of a new-psychotropic drug, Y-4153: comparative study with chlorpromazine using the double-blind method
  • ofInternational Medical Research 11,
  • 1972
...
1
2
...